(Total Views: 2247)
Posted On: 06/14/2025 8:39:20 AM
Post# of 154582
Dr. Sacha Project End Date
30-June-2025:
"These studies will determine the optimal clinical dosing of long-acting Leronlimab and lay the foundation for testing long-acting Leronlimab clinically as PREP in individuals at high-risk of acquiring HIV via sexual transmission."
reporter.nih.gov/project-de...
___
* 1st mention seen of human Long Acting.
FcRn human Long acting Leronlimab-PLS testing should also be close to trials, with the Switch now being discovered months ago.
Those 2 would/will, make outstanding press releases for LL.
Most likely reasons for cleaning up our trials profile on Clinicals gov.
Ready for human trials.
Finally a GF/GSK agreement ??
30-June-2025:
"These studies will determine the optimal clinical dosing of long-acting Leronlimab and lay the foundation for testing long-acting Leronlimab clinically as PREP in individuals at high-risk of acquiring HIV via sexual transmission."
reporter.nih.gov/project-de...
___
* 1st mention seen of human Long Acting.
FcRn human Long acting Leronlimab-PLS testing should also be close to trials, with the Switch now being discovered months ago.
Those 2 would/will, make outstanding press releases for LL.
Most likely reasons for cleaning up our trials profile on Clinicals gov.
Ready for human trials.
Finally a GF/GSK agreement ??
(9)
(0)
